- Home
- PTGX vs NEU Comparison
PTGX vs NEU Comparison
Compare PTGX & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | NEU |
|---|---|---|
| Founded | 2006 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.6B |
| IPO Year | 2016 | 2004 |
Fundamental Metrics
Financial Performance| Metric | PTGX | NEU |
|---|---|---|
| Price | $105.55 | $644.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $108.23 | N/A |
| AVG Volume (30 Days) | ★ 713.3K | 104.9K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 44.44 |
| Revenue | N/A | ★ $2,725,169,000.00 |
| Revenue This Year | $873.97 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.23 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $41.29 | $563.13 |
| 52 Week High | $107.84 | $875.97 |
Technical Indicators
Market Signals| Indicator | PTGX | NEU |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 52.80 |
| Support Level | $76.63 | $638.00 |
| Resistance Level | $107.84 | $646.28 |
| Average True Range (ATR) | 4.03 | 18.37 |
| MACD | -0.12 | 0.67 |
| Stochastic Oscillator | 84.57 | 51.00 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About NEU NewMarket Corp
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.